Glomerular leukotriene synthesis in Heymann nephritis  by Lianos, Elias A. et al.
Kidney International, Vol. 36 (1989), pp. 998—1002
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Glomerular leukotriene synthesis in Heymann nephritis. The glomer-
ular synthesis of LTB4 was assessed in glomeruli isolated from rats with
passive Heymann nephritis (PHN). PHN was induced by a single
intravenous administration of proteinuric doses of immune sera raised
in sheep against rat brush border tubular fraction FxlA. At various time
points following induction of the disease glomeruli were isolated and
LTD4 synthesis was assessed under basal and phospholipase A2 acti-
vation conditions. LTB4 was measured by high pressure liquid chroma-
tography and radioimmunoassay and was identified by UV spectros-
copy. The role of complement system in mediating glomerular LTB4
synthesis was also assessed in a group of deeomplemented rats using
cobra venom factor and at various time points following administration
of immune serum. Following induction of PHN, enhanced glomerular
LTD4 synthesis was observed as early as one hour, peaked at five hours
and returned toward control levels over the subsequent four days. The
peak in glomerular LTB4 synthesis did not correlate with changes in
glomerular neutrophiles or macrophages. A second increment of LTD4
synthesis occurred at the onset of heavy proteinuria (day 5). Comple-
ment depletion reduced proteinuria and the enhancement in LTD4
synthesis at day 5 but had no effect at earlier time points. The
observations indicate that in non-inflammatory forms of glomerular
immune injury the glomerular arachidonate 5-lipoxygenation is en-
hanced. This phenomenon has no apparent relationship with increased
glomerular permeability to protein and may reflect the presence or
activation of a leukotriene producing cell following intraglomerular
interactions of FxlA antigen, anti-FxIA antibody and complement.
The renal glomerulus and its various cell types synthesize
anachidonic acid metabolites (eicosanoids) with autacoid [1]
and proinflammatory [21 effects. The spectrum of proinflamma-
tory compounds of glomerular origin has recently expanded to
include the arachidonate lipoxygenation products. Under phos-
pholipase A2 stimulation, 12-lipoxygenation of arachidonate
was originally described in the normal glomerulus 131. It was
subsequently shown that glomerular arachidonate 5-lipoxygen-
ation leading to measurable amounts of leukotriene 134 (LTB4)
also occurs [4]. In antibody-mediated infiltrative forms of
glomerular immune injury, the glomerular synthesis of 12-
HETE or LTD4 is enhanced [5, 61. In these forms, infiltrating
platelets and neutrophils do not entirely account for the in-
creased glomerular levels of l2-HETE or LTB4, respectively.
Passive Heymann nephritis (PHN) is an antibody mediated,
complement dependent, non-infiltrative form of glomerular
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injury. As such, it offers an appropriate model to study glomer-
ular leukotriene synthesis resulting from interactions of immune
reactants (Fx1A, anti-Fx 1A) and the complement system within
glomerular structures and in the absence of blood-borne infil-
trating inflammatory cells. In the present study the glomerular
synthetic profiles of leukotrienes 134 and C4 were assessed at
various time points following induction of PHN and the role of
complement in mediating LT synthesis was evaluated.
Methods
Induction of PHN
PHN was induced in female Lewis rats (150 to 175 g) by a
single intravenous administration of proteinuric doses of sheep
immune serum raised against rat tubular brush border antigen
FxlA isolated according to the method described by Edgington,
Glassock and Dixon [7]. Prior to use sera were heat inactivated
at 56°C for 30 minutes and absorbed with rat peripheral blood
cells and liver powder. Alternatively, the IgG fraction of
immune sera was isolated by anion exchange column chroma-
tography using DE-52 (Bio-Rad Laboratories, Richmond, Cal-
ifornia, USA) as the cellulosic ion exchanger. Doses of 150 p.g
IgG per g body weight were employed in order induce the
disease. Glomerular injury was monitored by quantification of
urinary protein excretion [8] and glomerular lesions were as-
sessed by routine methods of electron microscopy and immu-
nofluorescence using fluorescein isothiocyanate labeled sera
against IgG and C3. The extent of glomerular deposition of rat
IgG and C3 was graded on the basis of a 0 to 3+ scale. Control
rats received identical doses of non-immune sheep sera.
Decomplementation studies
To assess the effect of complement depeletion on glomerular
leukotriene (LT) synthesis, PHN was induced in a group of rats
following complement depletion using purified cobra venom
factor (CVF) and glomerular LT levels were compared to those
obtained in rats in which PHN was induced without prior
decomplementation. Controls received CVF alone followed by
non-immune sheep serum or CVF vehicle. Prior to use, CVF
(Naja-naja, Cordis Laboratories, Miami, Florida, USA) was
purified to remove contaminating phospholipases by ion ex-
change chromatography followed by gel filtration as described
elsewhere [9]. Eluates were tested for CVF activity by a
hemolysis inhibition assay using sheep red blood cells sensi-
tized with rabbit anti-sheep hemolysin (Gibeo Laboratories,
Grand Island, New York, USA). Fractions exhibiting CVF
activity were subsequently pooled and concentrated to a final
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activity of 80 to 100 U/mI, determined as the amount of CVF in
0.1 ml eluate required to cause 50% inhibition of sensitized
sheep red blood cell lysis. To induce complement depletion,
rats received a single intraperitoneal injection of CVF, 40 U/l00
g body weight which, in pilot experiments, was found to be
sufficient to induce undetectable circulating C3 levels within 20
to 30 minutes. Upon documentation of decomplementation in
serum samples (75 d) obtained from the tail vein, PHN was
induced as described above and glomerular biochemical studies
were performed on days 1, 3, 4 and 5. In these animals, daily
doses of CVF (10 U/l00 g body wt) were given intraperitoneally
to maintain systemic complement depletion. The effect of
decomplementation on glomerular C3 deposition was assessed
by immunofluorescence.
Assessment of glomerular leukocytes
To correlate changes in glomerular LTB4 synthesis with
changes in glomerular population of leukocytes, isolated gb-
meruli were enzymatically permeabilized and stained for the
presence of leukocyte common (LC) antigen and Ia antigen
bearing leukocytes. Briefly, isolated glomeruli were exposed to
2 ml of Hanks' balanced salt solution containing 1% HEPES, 50
piml of collagenase Type II and 0.01% DNAase at room
temperature for 20 minutes under constant agitation. Glomeru-
lar suspensions were subsequently washed and incubated with
defined concentrations of monoclonal antibodies against rat Ia
or LC antigen (source: Accurate Scientific Corporation, West-
bury, New York, USA). Incubations were performed for 20
minutes at 4°C, following which glomeruli were washed and
incubated with fluorescein isothiocyanate conjugated goat anti-
mouse IgG for 20 minutes. Glomeruli were subsequently fixed
in 2% paraformaldehyde and examined for the presence of Ia or
LC antigen bearing cells. Twenty glomeruli were studied indi-
vidually at different focus levels through each glomerulus, and
results were expressed as mean standard deviation of Ia or
LC bearing cells per glomerulus.
Glomerular biochemical studies
These were performed at various time points following ad-
ministration of immune sera. Each animal was studied individ-
ually using ether anesthesia. At the various points of study,
nephrectomies were performed and kidneys were placed in ice
cold RPMI. Cortices were subsequently dissected, minced to a
paste-like consistency and glomeruli were isolated by differen-
tial sieving, suspended in 2 ml RPMI medium-l640 and incu-
bated at 37°C for 45 minutes in the presence (stimulated
synthesis) or absence (basal synthesis) of the phospholipase
activator, cationophore A23l87 (2 SM). Working solutions of
A23 187 (Sigma Chemical Co., St. Louis, Missouri, USA) were
made in dimethylsulfoxide and used at a final volume of 0.05%
of the total glomerular suspension. Suspensions were subse-
quently extracted with three volumes of ice-cold ethanol con-
taining 3500 to 4000 cpm of 3H-LTB4 "spike" and acidified WIifl
formic acid to pH 3.0 to 3.5. Following a 30 minute vigorous
agitation at 4°C to precipitate tissue protein, the glomerular
suspensions were centrifuged to separate tissue from the sol-
vent/aqueous phase mixture. The tissue pellet was dissolved in
1 ml sodium hydroxide, 0.5 N, to denature protein, and this
solution was used for glomerular protein determination [8, 9].
Supernates were dried under vacuum (Rotavap, Savant Instru-
ments, Farmingdale, New York, USA), reconstituted in 1 ml of
HPLC solvent (methanol: water, acidic acid. 65:35:0.02, pH
5.7) and injected into a high-pressure liquid chromatograph
consisting of two solvent delivery modules (Beckman 112,
Arlington Heights, Illinois, USA), a gradient controller (Ax-
xiom 710 HPLC controller; Anspec, Arlington Heights, Illinois,
USA) and a reverse phase C18, 5 jscartridge (Nova Pak, Waters
Associates, Milford, Massachusetts, USA) placed in a radial
compression module (RCM-l00, Waters Associates). Elutions
were performed at flow rates of 1 mI/mm. An initial isocratic
phase (15 mm) using methanol:water:acetic acid (65:35:0.02
vollvol), pH 5.7 adjusted with concentrated ammonium hydrox-
ide (solvent B), was followed by a progressive gradient to 100%
methanol over 30 minutes as previously described [6]. Leuko-
trienes were detected at A = 280 mm using an in line, variable
wavelength absorbance detector (Spectroflow 773, Kratos An-
alytical, Ramsey, New Jersey, USA) interfaced with an inte-
grator/printer plotter (SP 4270, Spectra Physics, Arlington
Heights, Illinois, USA). Elution fractions (1 ml) were collected
at one minute intervals, and those corresponding to retention
times of LTC4 and LTB4 standards were dried under vacuum
and reconstituted in 300 ml of 0.01 M phosphate buffer contain-
ing 0.1% bovine gamma globulin for subsequent quantification
by radioimmunoassay (RIA). LTC4 and LTB4 standards were
supplied by Dr. J. Rokach, Merck-Frosst Laboratories, Dorval,
P.Q., Canada. Recovery range of 3H-LTC4 and 3H-LTB4 added
in glomerular suspensions and recovered following extractions
and chromatographic separations were 60 to 72%. RIA's em-
ployed commercially available antibodies for LTC4 (New En-
gland Nuclear) and LTB4 (Amersham, Arlington Heights, Illi-
nois, USA). To perform the assays, in 0.1 ml of HPLC eluates
corresponding to LTC4 or LTB4 retention times and reconsti-
tuted in RIA buffer, 7,000 to 8,000 cpm of 3H-ligand dissolved in
100 p1 of buffer was added followed by 100 p1 of antibody used
at proper dilution. RIA reactants were subsequently incubated
at 4°C for 18 hours and bound antibody was separated from free
by the addition of dextran coated charcoal and centrifugation,
following which the radioactivity in supernates containing Ii-
gand-antibody complexes was measured by liquid scintillation.
Study groups
(a) Rats received a single intravenous injection of anti-Fx1A
immune serum and studied at 1 hr (N = 4), 5 hr (N = 4), 18 hr
(N 4), 48 hr (N = 6), day 3 (N = 8), day 4 (N = 5), day 5 (N
= 6), and day 12 (N = 5) thereafter. (b) Controls received
non-immune sheep sera and were studied in parallel (N =27 for
all time points). (c) Complement depleted rats received anti-
Fx1A immune sera and were sacrificed on days 1, 3, 4, and 5
thereafter (N = 17 for all time points). (d) Controls received
anti-Fx1A serum alone or CVF alone and were studied in
parallel.
Results
Figure 1A demonstrates a high pressure liquid chromatogram
of extracts obtained from A23 187 stimulated glomeruli isolated
from rats with PHN and studied at five hours following admin-
istration of anti-FxIA immunogbobulin. The peak at 27.5 min-
utes comigrated with LTB4 standard. When eluates correspond-
ing to this product were subjected to UV spectroscopy, the
configuration of a conjugated triene was obtained (Fig. 1 B) with
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Fig. 1. A. High pressure liquid chromatogram of
glomeruli-derived lipid extracts obtained from
rats with passive Heymann nephritis and studied
at 5 hours following induction of the disease.
Note LTB4 peak at 27.5 minutes. The peak at
14.5 minutes comigrated with LTC4 standard.
However, no immunoreactive LTC4 was found in
the corresponding eluates. An unidentified
product was also observed at 20 minutes. B.
Ultraviolet spectroscopy of glomeruli-derived and
HPLC purified LTB4.
Fig. 2. Glomerular LTB4 synthesis and /8-
hour urinary protein excretion levels at
various time points following induction of
PHN. In parallel, the extent of subepithelial
IgG deposit formation is shown. Enhanced
LTB4 synthesis occurred at early stages and
again on day 5. Asterisks indicate significant
increments in LTB4 synthesis or in 18-hour
urinary protein excretion at the 0.05 level
compared to the combined control values.
absorbance maxima at A = 261, 270 and 281, which were
identical to those of HPLC purified LTB4 standard. The peak at
14.5 minutes comigrated with LTC4 standard. However, the
amounts of LTC4 determined by RIA in the corresponding
eluates were below the detection limits of this assay. Figure 2
demonstrates the stimulated (A23187) synthesis of glomerular
LTB4 expressed in ng/mg glomerular protein and the 18-hour
urinary protein excretion at various time points of study. In
parallel, the extent of glomerular IgG deposition is demon-
strated. Glomerular LTB4 in control rats receiving non-immune
sheep serum was 1.63 0.18 ng/mg protein (N = 27, data
combined). Significant increments in LTB4 synthesis (P < 0.05)
were observed as early as one hour (10.22 1.35, N = 4) and
peaked at five hours (17.31 5.7, N = 5). LTB4 levels remained
elevated at 18 hours (7.62 2.88, N 4), 48 hours (3.36 0.57,
N = 6) and on day 3(2.69 0.05, N 7). On day 4, glomerular
LTB4 synthesis was 1.82 0.37 ng/mg proteinf45 mm (N = 5)
and was no different compared to the combined control value.
On day 5, enhanced glomerular LTB4 synthesis was again
observed (11.25 3.6, N = 6) and returned to levels not
significantly different from controls on day 12 (2.75 0.69, N =
5). Urinary protein excretion progressively increased after day
5 following administration of anti-Fx 1A (Fig. 2). In glomeruli
isolated from rats with PHN and incubated in the absence of
A23 187, LTB4 was below the detection limits of the RIA
employed (17 to 20 pg). In Figure 3, the effects of complement
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Table 1. Glomerular counts of Ia and LC antigen bearing leukocytes
at I to 8 hrs following administration of anti-Fx1A immune serum
PHN Control
La LC Ia LC
1—3 hours 9.8 2.9 8.3 2.2 10.1 3 7.3 2.0
5 hours 7.9 3.2 14.1 4.6 8.1 3.1 14.6 5.1
8 hours 5.3 1.7 8.7 2.8 11.1 3.8 9.9 4.8
Values are mean SD of cells counted in 20 individual glomeruli
isolated from rats with PHN at each time point.
Fig. 3. Effects of decoinpiementation on glomerular LTB4 synthesis.
Complement depletion using cobra venom factor abrogated increments
of glomerular LTB4 on day 5 but not at earlier time points. Asterisks
indicate significantly lower LTB4 values at the 0.05 level compared to
complement replete controls studied at day 5. Symbols are: solid bars,
anti-Fx 1 A serum; hatched bars, decomplemented animals receiving
anti-FxIA serum; open bar, animals studied after consecutive daily
injections of intraperitoneal cobra venom factor administration for 5
days.
depletion on glomerular LTB4 synthesis and proteinuria are
shown in decomplemented animals with PHN studied on days
1, 3, 4 and S following induction of the disease and in comple-
ment replete controls with PHN studied in parallel. In the
decomplemented group of rats, glomerular J.TB4 levels were no
different than complement replete controls except for animals
studied on day 5 in which the LTB4 levels were significantly
lower compared to those in the complement replete group with
PHN 3.00 0.45 (N = 5) compared to 11.25 3.6 (N = 6)
ng/mg protein, P < 0.05. However, LTB4 levels in the decom-
plemented group remained elevated compared to controls re-
ceiving non-immune sheep serum and studied on day 5(1.19
0.29, N = 8). In control rats receiving consecutive injections of
CVF alone and studied on day 5, glomerular LTB4 levels were
no different than controls receiving non-immune serum (1.88
0.13 compared to 1.63 0.18 ng/mg protein). In the decomple-
mented group of animals, glomerular deposits of C3 were
undetectable and the 18-hour protein excretion was markedly
lower (6.5 1.2 mg) compared to the complement replete group
with PHN (146 17.4 mg). Table 1 summarizes the values of
counted glomerular cells which were positive for Ia or LC
antigens at the early stages of PHN (Ito 3 hr, 5 hr and 8 hr) and
in parallel controls. No significant differences were noted
between PHN and control groups.
Discussion
Lipoxygenation of arachidonic acid generates hydroxyeico-
satetraenoic acids (HETE) and leukotrienes which exert potent
proinflammatory effects such as chemotaxis, chemokinesis,
enhancement of expression of C3b receptors, modest release of
lysosomal enzymes, contraction of smooth muscle cells and
changes in permeability of microvasculature [11]. Moreover,
the leukotrienes, and in particular LTC4 and LTD4. exert
important renal hemodynamic pertubations such as reduction in
glomerular filtration rate, renal plasma flow and the ultrafiltra-
tion coefficient [12]. The present study was prompted from
recent observations indicating that the rat glomerulus synthe-
sizes measurable amounts of LTB4 [4] and that the glomerular
synthesis of this eicosanoid is enhanced in antibody mediated
infiltrative forms of glomerular injury [6].
Our data indicate that in passive Heymann nephritis, which is
regarded to be the experimental equivalent of human membra-
nous nephropathy and in which glomerular injury and protein-
uria are dependent on intraglomerular activation of the comple-
ment system [13], the synthesis of LTB4 in isolated glomeruli is
enhanced. Since glomerular inflammatory cell infiltrates do not
occur in this model, nor were they observed in our studies
(Table 1), LTB4 may originate from cells present within glomer-
ular structures and activated following deposition of anti-FX1A
antibody and components of the complement system. Of inter-
est is the observation that enhanced LTB4 synthesis was
observed under stimulated conditions only in the presence of
the phospholipase activator A23 187 in glomerular preparations.
This indicates that under the experimental design and condi-
tions employed in our studies, A23 187 allows unmasking of an
enhanced activity of glomerular arachidonate 5-lipoxygenase in
immunologically injured glomeruli. Increased LTB4 synthesis
was observed as early as one hour and peaked at five hours
following administration of anti-Fx1A (Fig. 2). Although this
phenomenon coincided with the onset of formation of subepi-
thelial anti-FX 1 A immunoglobulin deposits, LTB4 levels pro-
gressively decreased despite a progressive increase in forma-
tion of these deposits. On day 5 and coincidental with
significant proteinuria, increments of glomerular LTB4 synthe-
sis were again observed and declined toward control levels on
day 12, despite progressively increasing proteinuria. This ap-
parent lack of correlation between extent of proteinuna and
LTB4 synthesis indicates that glomerular LTB4 synthesis may
have no mediatory effect on glomerular permeability to protein.
Decomplementation of animals using cobra venom factor
ameliorated LTB4 increments on day 5. At earlier time points
(days 1 and 3) decomplementation had no significant effect (Fig.
3). The reasons for this discrepancy are unclear. One may
speculate that at later stages of PHN a critical extent of
complement-mediated glomerular injury may be necessary in
order for changes in LTB4 synthesis to occur. Systemic com-
G
lo
m
er
ul
ar
 L
TB
4.
 n
g/
m
g p
ro
te
in
 
0 
C 
-
1 
N
!j * 
1002 Lianos and Noble: Leukotrienes in Heymann nephritis
plement activation induced by administration of cobra C3b do
not explain the maintenance of higher glomerular LTB4 levels in
decomplemented rats with PHN at day 5 compared to controls
receiving non-immune globulin (3.0 0.45 vs. 1.19 0.29),
since in previous studies it was demonstrated that in vitro
activation of the complement system in serum containing gb-
merular incubation media using C3b is not associated with
enhanced eicosanoid (PGE2, LTB4) synthesis [6]. In PHN, the
complement system plays a critical role in mediating glomerular
cell injury via formation of the membrane attack complex C5b-9
[13]. Moreover, this system was shown to mediate eicosanoid
synthesis in cultured rat glomerubar mesangial cells exposed to
antibody against rat thymocytes [14] as well as in nephrotoxic
serum nephritis 16]. The mechanism of complement mediated
increase in glomerular arachidonate lipoxygenation products is
unclear. It is conceivable that intraglomerular release of ana-
phylatoxins or formation of C5b-9 may enhance 5-lipoxygenase
activity. C5a has been shown to activate this enzyme in various
tissues such as lung and purified mixed cell populations [15].
The cellular origin of LTB4 in PHN remains to be explored.
Interactions between Fx 1 A, anti-Fx IA and complement are
known to occur primarily on glomerular epithelial cells, as are
interactions between cationized bovine gamma globulin and its
antibody in another model of noninfiltrative glomerulopathy in
which enhanced glomerular LTB4 synthesis was also observed
[16]. Yet, no definitive evidence exists to date that this cell type
possesses arachidonate 5-lipoxygenase activity. Another poten-
tial cellular source of LTB4 could be the glomerular resident
macrophage. This cell has been shown to significantly account
for the levels of LTB4 measured in isolated glomeruli [17]. As
increased numbers of these Ia bearing cells were not observed
in our studies (Table 1), one may speculate that an enhanced
state of activation of this cell type occurs following the inter-
actions of the FxIA-anti-FxlA system and complement, or
following the injury of the glomerular epithelial cell, The
increments in LTB4 synthesis observed could therefore reflect
an "elicited" monocyte macrophage. The significance of en-
hanced activity of this enzyme in PHN also remains to be
explored. Possible effects of increased intraglomerular LTB4
levels may include an enhanced expression of glomerular C3b
receptors and an immunoregulatory role on endogenous gb-
merular immunocompetent cells, such as the resident gbomeru-
lar macrophage.
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